ImmPACT Bio USA is developing novel cell therapies for treating cancer.
ImmPACT Bio has raised $8.0M in total funding. The most recent round was Grant. The last funding was announced in February 2024.
ImmPACT Bio's investors include OrbiMed, Foresite Capital, Decheng Capital, venBio Partners, Johnson & Johnson Innovation.
ImmPACT Bio is headquartered in Camarillo, United States.
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
ImmPACT Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ImmPACT Bio — Funding & Investors." VCBacked, February 28, 2024, https://www.vcbacked.co/company/immpact-bio. Accessed October 23, 2026.
VCBacked. (2024). ImmPACT Bio — Funding & Investors. Retrieved October 23, 2026, from https://www.vcbacked.co/company/immpact-bio
{{cite web |title=ImmPACT Bio — Funding & Investors |url=https://www.vcbacked.co/company/immpact-bio |website=VCBacked |access-date=October 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated